TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 147 filers reported holding TRANSLATE BIO INC in Q1 2021. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
Birchview Capital, LP | 30,000 | $553,000 | 0.32% |